Try it
General Medicine · Cardiology: clopidogrel activation
Sample itemA patient with a drug-eluting stent develops recurrent stent thrombosis although taking clopidogrel regularly. Genotyping shows two loss-of-function alleles in the gene for the hepatic enzyme that converts the drug to its active form. Which gene is this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. CYP2C19
Clopidogrel is a prodrug that needs hepatic activation, mainly by CYP2C19. Loss-of-function variants reduce active metabolite formation and platelet inhibition, and omeprazole competes for the same enzyme. Ticagrelor and prasugrel do not need this step.
Option by option
A. CYP2D6
CYP2D6 is mainly involved in activating codeine and tamoxifen.
B. CYP2C19 (correct)
Correct. CYP2C19 variants cause poor activation and clopidogrel resistance.
C. CYP3A4
CYP3A4 metabolises many drugs such as statins but is not the main step for clopidogrel.
D. CYP2C9
CYP2C9 metabolises warfarin and phenytoin.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…